EX-2.1 2 d624374dex21.htm EX-2.1 Execution Copy AGREEMENT AND PLAN OF MERGER dated as of November 7, 2013 among SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC. (solely for purposes of Section 2.1(b) and Sections 4.3(a), (d) and (e)), WILLOW...Merger Agreement • May 5th, 2020 • Delaware
Contract Type FiledMay 5th, 2020 JurisdictionAGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of November 7, 2013, among SALIX PHARMACEUTICALS, LTD., a Delaware corporation (“Parent”), SALIX PHARMACEUTICALS, INC., a California corporation, solely for purposes of Section 2.1(b) and Sections 4.3(a), (d) and (e) (“Intermediary”), WILLOW ACQUISITION SUB CORPORATION, a Delaware corporation and an indirect wholly owned subsidiary of Parent (“Merger Sub”), and SANTARUS, INC., a Delaware corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER dated as of November 7, 2013 among SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC. (solely for purposes of Section 2.1(b) and Sections 4.3(a), (d) and (e)), WILLOW ACQUISITION SUB CORPORATION and SANTARUS, INC.Merger Agreement • November 7th, 2013 • Salix Pharmaceuticals LTD • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 7th, 2013 Company Industry JurisdictionAGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of November 7, 2013, among SALIX PHARMACEUTICALS, LTD., a Delaware corporation (“Parent”), SALIX PHARMACEUTICALS, INC., a California corporation, solely for purposes of Section 2.1(b) and Sections 4.3(a), (d) and (e) (“Intermediary”), WILLOW ACQUISITION SUB CORPORATION, a Delaware corporation and an indirect wholly owned subsidiary of Parent (“Merger Sub”), and SANTARUS, INC., a Delaware corporation (the “Company”).